| Bioengineer + (8) |  |
| Bioprocess + (1) | |
| Bioscience + (23) | |
| Biotech companies (1) | |
| Biotechnology industry + (1) | |
| Biotechnology products + (1) | |
| Bioengineer + (8) | |
| Bioprocess + (1) | |
| Bioscience + (23) | |
| Biotech companies (1) | |
| Biotechnology industry + (1) | |
| Biotechnology products + (1) | |
Caribou Biosciences, to commercialize her work. In the short term, Church says, the potential of cas9 is that it could be used to study genetics in a way that was heretofore impossible.
Sangamo Biosciences has been working to commercialize the earlier zinc finger nuclease technology as a form of medicine for more than a decade.
For one of the new studies, Shukla and her colleagues at Dow Agrosciences teamed up with Sangamo Biosciences
Steve Long, a crop scientist and deputy director of the Energy Biosciences Institute in Urbana, Illinois, says companies are struggling to overcome a suite of financial,
says Johan Botterman, head of product research at Bayer Bioscience in Ghent, Belgium. The technique is established well for many crops,
and Sangamo Biosciences in Richmond, California, announced that they had used enzymes called zinc-finger nucleases to insert a gene for herbicide resistance at a specific site in the maize genome (V. K. Shukla et al.
Brown is working on the project through the Energy Biosciences Institute at the U of I hoping to use the sorghum findings as a launching pad for working with complex genomes of other feedstocks.
The research was done at the Energy Biosciences Institute a collaboration in which bioscience and biological techniques are being applied to help solve the global energy challenge.
The partnership funded from the energy company BP includes researchers from the University of California Berkeley;
Geosciences and Biosciences Office of Basic Energy Sciences of the Department of energy. Chen was supported partially by the China Scholarship Council.
Now researchers with the Lawrence Berkeley National Laboratory (Berkeley Lab) through support from the Energy Biosciences Institute (EBI) have shed literally new light on cellulase catalysis. Using an ultrahigh-precision visible light microscopy
Jonathan R. Mielenz group leader of the bioscience and technology biosciences division at the Oak ridge National Laboratory who is familiar with Zhang's work
Geosciences and Biosciences Office of Basic Energy Sciences of the Department of energy. The lead author of the article Julia S. Martin Del Campo who works in Zhang's lab received her Ph d. grant from the Mexican Council of Science and Technology.
and more effective toxicity tests for airborne chemicals scientists from Rice university and the Rice spinoff company Nano3d Biosciences have used magnetic levitation to grow some of the most realistic lung tissue ever produced in a laboratory.
Killian and fellow scientists from Rice and the University of Texas MD Anderson Cancer Center co-founded Nano3d Biosciences in 2009 after creating a technology that uses magnetism to levitate
Nano3d Biosciences won a Small Business Innovation Research (SBIR grant from the National Science Foundation (NSF) in 2011 to create a four-layered lung tissue from endothelial cells smooth muscle cells
and layers of in vitro bronchiole tissue created at Rice university and Nano3d Biosciences. The cell layers include epithelial cells (Epic) smooth muscle cells (SMC) pulmonary fibroblasts (PF) and pulmonary endothelial cells (PEC.
Study co-authors include Robert Raphael professor of bioengineering at Rice and cofounder of Nano3d Biosciences;
and former BCM scientist Jacob Gage now with Nano3d Biosciences. The research was funded by NSF and the Texas Emerging Technologies Fund.
Dupont's big bioscience bets: butanol, cellulosic ethanol, omega-3 acidsnew YORK--Dupont wants to help raiseã Â sustainably-farmed salmon by offering them a diet loaded with omega-3 fatty acids that it manufactures from soybeans.
Binetti, theã Â president of Dupont's Nutrition & Health and Applied Biosciences divisions, says he sees large potential market opportunities for his group that will lead to 7 percent annual growth
The Applied Biosciences division, which counts $1 billion in revenue, is comprised of two primary businesses:
< Back - Next >
Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011